The global healthcare landscape is undergoing a significant transformation, and at the heart of this revolution is the growing role of biomarkers. Biomarkers are measurable indicators of biological processes, conditions, or diseases, often used in diagnostics, drug development, and personalized medicine. The biomarkers market has experienced remarkable growth over the past decade, and this trend is expected to continue as technological advancements, increased healthcare spending, and a shift toward precision medicine drive demand.
Biomarkers are biological molecules that provide insights into the underlying processes of disease or health conditions. They can be found in blood, urine, saliva, or other bodily fluids, and can include genetic information, proteins, metabolites, or even DNA sequences. Biomarkers are broadly categorized into three types:
These markers are pivotal for tailoring healthcare to individual needs, offering more accurate and effective treatments, and enhancing overall patient care.